内容简介
AccordingtotheWHO,170millionpeople,or3%oftheworld'spopulation,areinfectedwithHepatitisCandatriskofdevelopinglivercirrhosisand/orlivercancer.3-4millionpeopleeachyeararenewlydiagnosedcarriersofthevirus.AdvancedTherapyforHepatitisCInfectionprovidesyouwithexpertguidancefromtheworld'sleadinghepatologistsontheverylatesttreatmentoptionsforpatientswiththeHCVvirus.Focusingmainlyontheefficacyandclinicaluseofantiviraltherapies,keytopicsinclude:TreatmentofrecurrenthepatitisCfollowinglivertransplantationAntiviralsinCirrhosisandPortalHypertensionHIVandHepatitisCco-infectionCytopenias:howtheylimittherapyandpotentialcorrectionTheproblemofinsulinresistanceanditseffectontherapyAntiviralsinAcuteHepatitisCInaddition,itfullycoversthefoundationsforunderstandingantiviraltherapiesinHCV,suchasthecomplexpharmacologyandmechanismsofantiviraldrugs.Finally,achapteronNewHorizons:Interleukin28anddirect-actingantiviraltherapyforHCV,offersyouaglimpseintothefuturepossibilitiesforHCVtherapy.Editedbyateamofoutstandinginternationalreputation,AdvancedTherapyforHepatitisCInfectionisanessentialtoolforallhepatologistsandgastroenterologistsinvolvedinthemanagementofpatientswithHepatitisC.